Crosspoint Capital Strategies’s Johnson & Johnson JNJ Stock Holding History

Crosspoint Capital Strategies’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-21,065	Closed	-$2.2M	–	491
2015 Q4	$2.2M	Buy	21,065 +13,371	+174%	+$1.34M	0.58%	60
2015 Q3	$718K	Sell	7,694 -3,255	-30%	-$315K	0.83%	28
2015 Q2	$1.07M	Sell	10,949 -509	-4%	-$51K	0.3%	67
2015 Q1	$1.15M	Buy	11,458 +214	+2%	+$21.8K	0.56%	55
2014 Q4	$1.18M	Buy	11,244 +7,986	+245%	+$842K	0.41%	74
2014 Q3	$347K	Sell	3,258 -14	-0.4%	-$1.45K	0.26%	73
2014 Q2	$334K	Sell	3,272 -983	-23%	-$99.4K	0.13%	106
2014 Q1	$418K	Sell	4,255 -19	-0.4%	-$1.76K	0.17%	96
2013 Q4	$399K	Buy	+4,274	New	+$394K	0.13%	107

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Crosspoint Capital Strategies's JNJ Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Johnson & Johnson (JNJ) in Q1 2016, closing a stake of 21,065 shares — an estimated $2.2M sold.

Crosspoint Capital Strategies first reported a position in JNJ in Q4 2013 and held it in 9 quarters. The position peaked at $2.2M in Q4 2015. 2,204 funds tracked by Wall St. Rank hold JNJ as of Q1 2016.

Crosspoint Capital Strategies reported no remaining Johnson & Johnson position as of Q1 2016 after selling out during the quarter.
Crosspoint Capital Strategies sold 21,065 Johnson & Johnson shares in Q1 2016, an estimated $2.2M.
Crosspoint Capital Strategies first reported a position in Johnson & Johnson in Q4 2013 and held it in 9 quarters.
Crosspoint Capital Strategies's Johnson & Johnson position peaked at $2.2M in Q4 2015.
2,204 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.